Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225751408> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4225751408 abstract "Individuals with type 1 diabetes have an impaired glucagon counterregulatory response to hypoglycemia. Sodium-glucose cotransporter (SGLT) inhibitors increase glucagon concentrations. We evaluated whether SGLT inhibition restores the glucagon counterregulatory hormone response to hypoglycemia. Adults with type 1 diabetes (<i>n</i> = 22) were treated with the SGLT2 inhibitor dapagliflozin (5 mg daily) or placebo for 4 weeks in a randomized, double-blind, crossover study. After each treatment phase, participants underwent a hyperinsulinemic hypoglycemic clamp. Basal glucagon concentrations were 32% higher following dapagliflozin versus placebo, with a median within-participant difference of 2.75 pg/mL (95% CI 1.38-12.6). However, increased basal glucagon levels did not correlate with decreased rates of hypoglycemia, and thus do not appear to be protective in avoiding hypoglycemia. During hypoglycemic clamp, SGLT2 inhibition did not change counterregulatory hormone concentrations, time to recovery from hypoglycemia, hypoglycemia symptoms, or cognitive function. Thus, despite raising basal glucagon concentrations, SGLT inhibitor treatment did not restore the impaired glucagon response to hypoglycemia. We propose that clinical reduction in hypoglycemia associated with these agents is a result of changes in diabetes care (e.g., lower insulin doses or improved glycemic variability) as opposed to a direct, physiologic effect of these medications on alpha cell function." @default.
- W4225751408 created "2022-05-05" @default.
- W4225751408 creator A5045882994 @default.
- W4225751408 creator A5059225775 @default.
- W4225751408 creator A5064342620 @default.
- W4225751408 creator A5086256072 @default.
- W4225751408 date "2021-12-02" @default.
- W4225751408 modified "2023-09-29" @default.
- W4225751408 title "SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants with Type 1 Diabetes" @default.
- W4225751408 doi "https://doi.org/10.2337/figshare.17064497" @default.
- W4225751408 hasPublicationYear "2021" @default.
- W4225751408 type Work @default.
- W4225751408 citedByCount "0" @default.
- W4225751408 crossrefType "posted-content" @default.
- W4225751408 hasAuthorship W4225751408A5045882994 @default.
- W4225751408 hasAuthorship W4225751408A5059225775 @default.
- W4225751408 hasAuthorship W4225751408A5064342620 @default.
- W4225751408 hasAuthorship W4225751408A5086256072 @default.
- W4225751408 hasBestOaLocation W42257514081 @default.
- W4225751408 hasConcept C126322002 @default.
- W4225751408 hasConcept C134018914 @default.
- W4225751408 hasConcept C142724271 @default.
- W4225751408 hasConcept C204787440 @default.
- W4225751408 hasConcept C27081682 @default.
- W4225751408 hasConcept C2777180221 @default.
- W4225751408 hasConcept C2777391703 @default.
- W4225751408 hasConcept C2777422806 @default.
- W4225751408 hasConcept C2778024521 @default.
- W4225751408 hasConcept C2778563252 @default.
- W4225751408 hasConcept C2778808658 @default.
- W4225751408 hasConcept C2779306644 @default.
- W4225751408 hasConcept C2780352109 @default.
- W4225751408 hasConcept C2780473172 @default.
- W4225751408 hasConcept C2780668416 @default.
- W4225751408 hasConcept C555293320 @default.
- W4225751408 hasConcept C71924100 @default.
- W4225751408 hasConcept C87813604 @default.
- W4225751408 hasConceptScore W4225751408C126322002 @default.
- W4225751408 hasConceptScore W4225751408C134018914 @default.
- W4225751408 hasConceptScore W4225751408C142724271 @default.
- W4225751408 hasConceptScore W4225751408C204787440 @default.
- W4225751408 hasConceptScore W4225751408C27081682 @default.
- W4225751408 hasConceptScore W4225751408C2777180221 @default.
- W4225751408 hasConceptScore W4225751408C2777391703 @default.
- W4225751408 hasConceptScore W4225751408C2777422806 @default.
- W4225751408 hasConceptScore W4225751408C2778024521 @default.
- W4225751408 hasConceptScore W4225751408C2778563252 @default.
- W4225751408 hasConceptScore W4225751408C2778808658 @default.
- W4225751408 hasConceptScore W4225751408C2779306644 @default.
- W4225751408 hasConceptScore W4225751408C2780352109 @default.
- W4225751408 hasConceptScore W4225751408C2780473172 @default.
- W4225751408 hasConceptScore W4225751408C2780668416 @default.
- W4225751408 hasConceptScore W4225751408C555293320 @default.
- W4225751408 hasConceptScore W4225751408C71924100 @default.
- W4225751408 hasConceptScore W4225751408C87813604 @default.
- W4225751408 hasLocation W42257514081 @default.
- W4225751408 hasLocation W42257514082 @default.
- W4225751408 hasLocation W42257514083 @default.
- W4225751408 hasOpenAccess W4225751408 @default.
- W4225751408 hasPrimaryLocation W42257514081 @default.
- W4225751408 hasRelatedWork W1972088904 @default.
- W4225751408 hasRelatedWork W2018460003 @default.
- W4225751408 hasRelatedWork W2048352852 @default.
- W4225751408 hasRelatedWork W2083753940 @default.
- W4225751408 hasRelatedWork W2091233188 @default.
- W4225751408 hasRelatedWork W2160593192 @default.
- W4225751408 hasRelatedWork W3023111068 @default.
- W4225751408 hasRelatedWork W3093769985 @default.
- W4225751408 hasRelatedWork W4240985052 @default.
- W4225751408 hasRelatedWork W96794780 @default.
- W4225751408 isParatext "false" @default.
- W4225751408 isRetracted "false" @default.
- W4225751408 workType "article" @default.